<DOC>
	<DOC>NCT02934295</DOC>
	<brief_summary>The aim of the research is to study humoral and cellular immunity in pregnant women for who the level of rubella virus antibodies is weakly positive, equivocal or negative with the usual laboratory technique.</brief_summary>
	<brief_title>Study of Rubella Immunity. Response to Vaccination of Subjects With Very Low, Equivocal or Undetectable Titers of Rubella Virus Antibodies</brief_title>
	<detailed_description />
	<mesh_term>Rubella</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<mesh_term>Immunoglobulins</mesh_term>
	<criteria>Women over 18 Rubella serology negative, ambiguous or weakly positive during a first prenatal consultation and for which the second determination of the immunity anti rubella is necessary after 18 weeks of pregnancy Accepting the rubella vaccination after the childbirth; Accepting a blood test, during a postnatal consultation, 6 in 8 weeks after vaccination, to verify their immunity towards the virus of the rubella. Affiliated to a social security scheme Having given a written consent Rubella contracted since the first serology realized during the first prenatal consultation Autoimmune pathologies Intolerance / allergy known about a previous vaccination whatever it is Immunosuppression (HIV, transplants) Injection of multivalent immunoglobulins (except antiD)</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Rubeola</keyword>
</DOC>